New ointment RSS0393 aims to clear psoriasis in major trial
NCT ID NCT07543224
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tests whether RSS0393 ointment can improve plaque psoriasis compared to a placebo. About 600 adults with mild-to-moderate psoriasis will apply the ointment daily for 8 weeks. The main goal is to see if more people achieve clear or almost-clear skin with RSS0393 than with placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- RSS0393 ointment
- What this could lead to
- If it works, this could provide a new topical treatment option for plaque psoriasis, helping to clear skin and reduce itching.
- What could go wrong
- This is a phase 3 trial, but results are not yet available. The ointment may not work better than placebo, and side effects are possible. It is not a cure, as psoriasis typically requires ongoing management.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS SUBJECTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking Union Medical College Hospital (PUMCH)
Beijing, Beijing Municipality, 100730, China